Suppr超能文献

[血管肿瘤和血管畸形的分类。国际血管性病变研究学会(ISSVA)2014/2018分类的贡献]

[Classification of vascular tumours and vascular malformations. Contribution of the ISSVA 2014/2018 classification].

作者信息

Wassef Michel, Borsik Michel, Cerceau Pierre, Faucon Benoit, Laurian Claude, Le Clerc Nicolas, Lemarchand-Venencie Françoise, Massoni Claudine, Salvan Didier, Bisdorff-Bresson Annouk

机构信息

Service d'anatomie et cytologie pathologiques, hôpital Lariboisière, APHP ; UFR de médecine Paris nord, université de Paris, 2, rue Ambroise-Paré, 75475 Paris cedex, France; Consultation des angiomes, service de neuroradiologie, hôpital Lariboisière, APHP, 2, rue Ambroise-Paré 75475 Paris cedex, France.

Consultation des angiomes, service de neuroradiologie, hôpital Lariboisière, APHP, 2, rue Ambroise-Paré 75475 Paris cedex, France; Maison médicale, 9, rue Jean-Jacques-Bernard, 60200 Compiègne, France.

出版信息

Ann Pathol. 2021 Feb;41(1):58-70. doi: 10.1016/j.annpat.2020.11.004. Epub 2020 Dec 10.

Abstract

The study of vascular anomalies, "angiomas", vascular tumours and vascular malformations is made difficult by the great variety and confusion of the names used in the literature for these diseases, some of which are rare. The great merit of the classification proposed by the International Society for the Study of Vascular Anomalies (ISSVA), adopted in 2014 and modified in 2018, is to propose a unambiguous nomenclature and to try to group these lesions in a logical way, contrasting with the lists of the usual "classifications". This classification is based on the distinction between proliferative lesions (tumours and reactive lesions) and those which are due to a congenital anomaly of vascular morphogenesis (vascular malformations). It incorporates recent data on the molecular causes of these diseases. The major groups of lesions recognised in this classification will be presented and some lesions of interest briefly discussed. This classification aims to be usable by all medical specialties and applicable to all tissues and organs, even if efforts are still needed to integrate organ-specific names in order to unify the nomenclature and eliminate confusion. Even if it does not solve all the problems in this complex field, the unification of the nomenclature is a major contribution of this classification and pathologists are strongly encouraged to refer to it in daily practice.

摘要

血管异常(“血管瘤”)、血管肿瘤和血管畸形的研究存在困难,原因在于文献中用于这些疾病的名称种类繁多且混乱,其中一些疾病较为罕见。国际血管异常研究学会(ISSVA)于2014年采用并于2018年修订的分类法的一大优点是提出了明确的命名法,并试图以合乎逻辑的方式对这些病变进行分组,这与常见的“分类”列表形成对比。该分类基于增殖性病变(肿瘤和反应性病变)与因血管形态发生先天性异常导致的病变(血管畸形)之间的区别。它纳入了有关这些疾病分子病因的最新数据。将介绍该分类中认可的主要病变组,并简要讨论一些相关病变。该分类旨在供所有医学专业使用,并适用于所有组织和器官,尽管仍需努力整合特定器官的名称以统一命名法并消除混淆。即使它不能解决这个复杂领域中的所有问题,但命名法的统一是该分类的一项重大贡献,强烈鼓励病理学家在日常实践中参考它。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验